Covered recipient · General Payments record
SOUHEIL MOUSSLY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2022
$2,981.27
- Reported across 179 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $178.39 | 12 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $48.00 | 3 |
| Novo Nordisk AS | $44.40 | 3 |
| Lilly USA, LLC | $35.02 | 2 |
| Abbott Laboratories | $25.99 | 2 |
| Acerta Pharma LLC | $24.98 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $12.29 | 03/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 914128159 | CMS |
| Abbott Laboratories | $13.70 | 05/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 908546473 | CMS |
| ABBVIE INC. | $18.09 | 01/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891210941 | CMS |
| ABBVIE INC. | $12.60 | 02/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891210943 | CMS |
| ABBVIE INC. | $17.31 | 04/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891210945 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.86 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915029375 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.12 | 02/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915184829 | CMS |
| Lilly USA, LLC | $16.67 | 02/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918309055 | CMS |
| Lilly USA, LLC | $18.35 | 03/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918305409 | CMS |
| Novo Nordisk Inc | $14.58 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 916492143 | CMS |
| Novo Nordisk Inc | $17.68 | 03/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 916486629 | CMS |
| Novo Nordisk Inc | $12.14 | 04/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 916487619 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.